Development of Horse-Riding Program Model for Children With Cerebral Palsy
NCT ID: NCT03041818
Last Updated: 2018-05-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2017-03-14
2017-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Hippotherapy on Physical Fitness and Attention in Cerebral Palsy
NCT03870893
Observational Study of the Conjugated Rehabilitation on Children With Cerebral Palsy
NCT02223741
Rhythm Effect on Dance Learning in Typical Development Children and Children With Motor Disorders.
NCT06137625
Health Related Lifestyle and Quality of Life in Children With Cerebral Palsy
NCT03277027
A Comparative Analysis on Physical Activity Performance and Motor Function of Affected Upper Extremity Before and After a CIMT Program in Young Children With Hemiparetic Cerebral Palsy
NCT03418519
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Children older than 4 years old or adolescent with cerebral palsy who voluntarily want to enroll this study would be enrolled.
Participants have 2 times of 30-minute horse riding program for 8 weeks, total 16 times of riding program in a local horse riding center.
Sample size assessment: Calculating for 20% of drop out, 16 patients were calculated to apply the assessment and applicable program.
Drop out: missing more than 2 lessons of horse-riding
Plan for missing data: not included
Statistical analysis plan: paired t-test for the outcome measures
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
hippotherapy
16 sessions of horseback riding therapy
Horseback riding therapy
Apply 30 minutes/session, twice a week for 8 weeks of horseback riding therapy (provided with 1 horse rider, 2 side walkers)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Horseback riding therapy
Apply 30 minutes/session, twice a week for 8 weeks of horseback riding therapy (provided with 1 horse rider, 2 side walkers)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* GMFCS level I, II, III
* Body weight less than 80 kg
Exclusion Criteria
* Social condition who are not suitable for hippotherapy
5 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Konkuk University
OTHER
Samsung Medical Center
OTHER
The Catholic University of Korea
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bo Young Hong
Assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bo Young Hong, MD
Role: PRINCIPAL_INVESTIGATOR
St.Vincent's hospital, The Catholic University of Korea
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Vincent's hospital
Suwon, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
316086-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.